Growth Allocation Ishares Core ETF (AOR)

N/A +N/A (N/A)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume N/A
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund is a fund of funds and seeks its investment objective by investing primarily in underlying funds that themselves seek investment results corresponding to their own respective underlying indexes. It generally will invest at least 80% of its assets in the component securities of its underlying index. The index measures the performance of the S&P Dow Jones Indices LLC proprietary allocation model.

Phone: 1-800-474-2737
StocktwitsNews
StocktwitsNews Dec. 24 at 5:39 PM
Lumentum Stock On Track To Record 8th Consecutive Monthly Gain – What’s Making Analysts So Bullish? $LITE $EHLS $AOR $MEME $IJK https://stocktwits.com/news/equity/markets/lumentum-stock-on-track-to-record-8th-consecutive-monthly-gain-what-s-making-analysts-so-bullish/cLetbzjREv8
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 23 at 9:30 PM
Ford Tops US Auto Recall List In 2025 With 150 Recalls, Stellantis Trails—Tesla Ranks Far Lower $F $SPXV $AOR https://stocktwits.com/news/equity/markets/ford-tops-us-auto-recall-list-in-2025-with-150-recalls-stellantis-trails/cLep66dREHj
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 22 at 1:18 PM
CACI International To Acquire ARKA From Blackstone Funds In $2.6B Cash Deal $CACI $EAOR $AOR https://stocktwits.com/news/equity/markets/caci-international-to-acquire-arka-from-blackstone-funds-in-2-6-b-cash-deal/cLeF0pSREM4
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 19 at 12:02 PM
Why Did Coty Offload Wella From Its Portfolio? $COTY $KKR $DWSH $AOR $ITOT https://stocktwits.com/news/equity/markets/why-did-coty-offload-wella-from-its-portfolio-1/cLeiuBJREsT
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 25 at 2:36 PM
Sarepta Wins FDA Approval To Begin Study On Reducing Liver Injury Risk With Elevidys $SRPT $DWSH $AOR https://stocktwits.com/news/equity/markets/sarepta-wins-fda-approval-to-begin-study-on-reducing-liver-injury-risk-with-elevidys/cL52SFSREX6
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 24 at 7:13 PM
Why Did INSP Stock Soar 29% Today? $INSP $EAOR $AOR https://stocktwits.com/news/equity/markets/why-did-insp-stock-soar-today/cL5bSxXREQx
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 4 at 12:51 PM
Uber Delivers Solid Earnings, But Tepid Q4 Guidance Sends Stock Lower $UBER $AOR $PNQI https://stocktwits.com/news/equity/markets/uber-delivers-solid-earnings-but-tepid-q4-guidance-sends-stock-lower/cL28OsbR365
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 4 at 12:22 PM
Pfizer Raises Full-Year Earnings Guidance, Q3 Numbers Beat Street Estimates $PFE $AOR $EAOR https://stocktwits.com/news/equity/markets/pfizer-raises-full-year-earnings-guidance-q3-numbers-beat-street-estimates/cL28ObZR3Cz
1 · Reply
StocktwitsNews
StocktwitsNews Oct. 23 at 1:41 PM
American Airlines Names Aviation Veteran Nathaniel Pieper As Chief Commercial Officer $AAL $VFMF $AOR https://stocktwits.com/news/equity/markets/american-airlines-names-aviation-veteran-nat-pieper-as-chief-commercial-officer/cLG41OxR3rP
0 · Reply
StocktwitsNews
StocktwitsNews Oct. 14 at 6:11 PM
Polaris Stock Gets Price Target Hikes After Selling Indian Bike Business To Private Equity Firm $PII $IWMW $AOR https://stocktwits.com/news/equity/markets/polaris-stock-gets-price-target-on-polaris-over-decision-to-separate-indian-bike-business-to-private-equity-firm/ch6mU7LR3Z4
0 · Reply
Latest News on AOR
60/40 Portfolio Comeback: AOR ETF Matches S&P 500 Return So Far (Downgrade)

Oct 17, 2025, 7:04 PM EDT - 2 months ago

60/40 Portfolio Comeback: AOR ETF Matches S&P 500 Return So Far (Downgrade)

AOR Can Be The Passive Investor's Answer To No-Maintenance Investing

Aug 5, 2025, 6:14 PM EDT - 5 months ago

AOR Can Be The Passive Investor's Answer To No-Maintenance Investing

Enough With 60/40, Consider 100% Dividend Strategy For Retirement

Apr 18, 2025, 9:15 AM EDT - 8 months ago

Enough With 60/40, Consider 100% Dividend Strategy For Retirement

ADC BIP ENB EPD FDUS KBDC O

AOR: Passive Fund For Investors With Moderate Risk Tolerance

Sep 9, 2024, 1:17 AM EDT - 1 year ago

AOR: Passive Fund For Investors With Moderate Risk Tolerance

AOR: A Balanced Portfolio But Not Growth Oriented

Jun 10, 2024, 11:07 PM EDT - 1 year ago

AOR: A Balanced Portfolio But Not Growth Oriented

AOR: Not The Most Capital-Efficient 60/40 ETF

Jan 29, 2024, 6:46 PM EST - 2 years ago

AOR: Not The Most Capital-Efficient 60/40 ETF

AOR: 60/40 Looks Appealing Again

Nov 6, 2023, 3:33 PM EST - 2 years ago

AOR: 60/40 Looks Appealing Again

AOR: Fed Is Still Hawkish

Jul 12, 2023, 1:13 PM EDT - 2 years ago

AOR: Fed Is Still Hawkish

AOR: Global 60/40 Attractive On Valuation And Yield With One Key Technical Price Level

Mar 13, 2023, 8:59 AM EDT - 3 years ago

AOR: Global 60/40 Attractive On Valuation And Yield With One Key Technical Price Level

AOR: After A Rough 2022 For 60/40 And This ETF, Outlook Is No Better

Dec 24, 2022, 1:01 AM EST - 3 years ago

AOR: After A Rough 2022 For 60/40 And This ETF, Outlook Is No Better

AOR Fails To Add Value To Its Parts

Dec 23, 2022, 6:56 PM EST - 3 years ago

AOR Fails To Add Value To Its Parts

AOR: The Viability Of The 60/40 Portfolio In Today's Environment

Sep 16, 2022, 8:23 AM EDT - 3 years ago

AOR: The Viability Of The 60/40 Portfolio In Today's Environment

AOR: Lower Volatility, Softer Returns

Sep 5, 2022, 3:53 AM EDT - 3 years ago

AOR: Lower Volatility, Softer Returns

AOR: Fairly Valued But Not A Great Diversified Amidst Global Inflationary Pressures

Jun 19, 2022, 2:03 AM EDT - 3 years ago

AOR: Fairly Valued But Not A Great Diversified Amidst Global Inflationary Pressures

AOR: Keep It Simple With This 60/40 Multi-Asset Allocation ETF

Mar 1, 2022, 11:18 PM EST - 4 years ago

AOR: Keep It Simple With This 60/40 Multi-Asset Allocation ETF

IShares Core Growth Allocation ETF: Capital Preservation First

Sep 11, 2021, 9:34 AM EDT - 4 years ago

IShares Core Growth Allocation ETF: Capital Preservation First

AOR: iShares Provides Investors With A Fixed 60/40 Global Equity/Fixed Income ETF

May 22, 2021, 11:20 AM EDT - 4 years ago

AOR: iShares Provides Investors With A Fixed 60/40 Global Equity/Fixed Income ETF

StocktwitsNews
StocktwitsNews Dec. 24 at 5:39 PM
Lumentum Stock On Track To Record 8th Consecutive Monthly Gain – What’s Making Analysts So Bullish? $LITE $EHLS $AOR $MEME $IJK https://stocktwits.com/news/equity/markets/lumentum-stock-on-track-to-record-8th-consecutive-monthly-gain-what-s-making-analysts-so-bullish/cLetbzjREv8
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 23 at 9:30 PM
Ford Tops US Auto Recall List In 2025 With 150 Recalls, Stellantis Trails—Tesla Ranks Far Lower $F $SPXV $AOR https://stocktwits.com/news/equity/markets/ford-tops-us-auto-recall-list-in-2025-with-150-recalls-stellantis-trails/cLep66dREHj
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 22 at 1:18 PM
CACI International To Acquire ARKA From Blackstone Funds In $2.6B Cash Deal $CACI $EAOR $AOR https://stocktwits.com/news/equity/markets/caci-international-to-acquire-arka-from-blackstone-funds-in-2-6-b-cash-deal/cLeF0pSREM4
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 19 at 12:02 PM
Why Did Coty Offload Wella From Its Portfolio? $COTY $KKR $DWSH $AOR $ITOT https://stocktwits.com/news/equity/markets/why-did-coty-offload-wella-from-its-portfolio-1/cLeiuBJREsT
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 25 at 2:36 PM
Sarepta Wins FDA Approval To Begin Study On Reducing Liver Injury Risk With Elevidys $SRPT $DWSH $AOR https://stocktwits.com/news/equity/markets/sarepta-wins-fda-approval-to-begin-study-on-reducing-liver-injury-risk-with-elevidys/cL52SFSREX6
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 24 at 7:13 PM
Why Did INSP Stock Soar 29% Today? $INSP $EAOR $AOR https://stocktwits.com/news/equity/markets/why-did-insp-stock-soar-today/cL5bSxXREQx
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 4 at 12:51 PM
Uber Delivers Solid Earnings, But Tepid Q4 Guidance Sends Stock Lower $UBER $AOR $PNQI https://stocktwits.com/news/equity/markets/uber-delivers-solid-earnings-but-tepid-q4-guidance-sends-stock-lower/cL28OsbR365
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 4 at 12:22 PM
Pfizer Raises Full-Year Earnings Guidance, Q3 Numbers Beat Street Estimates $PFE $AOR $EAOR https://stocktwits.com/news/equity/markets/pfizer-raises-full-year-earnings-guidance-q3-numbers-beat-street-estimates/cL28ObZR3Cz
1 · Reply
StocktwitsNews
StocktwitsNews Oct. 23 at 1:41 PM
American Airlines Names Aviation Veteran Nathaniel Pieper As Chief Commercial Officer $AAL $VFMF $AOR https://stocktwits.com/news/equity/markets/american-airlines-names-aviation-veteran-nat-pieper-as-chief-commercial-officer/cLG41OxR3rP
0 · Reply
StocktwitsNews
StocktwitsNews Oct. 14 at 6:11 PM
Polaris Stock Gets Price Target Hikes After Selling Indian Bike Business To Private Equity Firm $PII $IWMW $AOR https://stocktwits.com/news/equity/markets/polaris-stock-gets-price-target-on-polaris-over-decision-to-separate-indian-bike-business-to-private-equity-firm/ch6mU7LR3Z4
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 30 at 6:30 PM
Ford CEO Jim Farley Reportedly Expects US EV Demand To Decline Sharply – Here’s Why $F $IOO $AOR https://stocktwits.com/news/equity/markets/ford-ceo-jim-farley-reportedly-expects-us-ev-demand-to-decline-sharply/chDDKScR39m
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 24 at 5:45 PM
Harmony Biosciences Stock Slumps After Rare Genetic Disorder Drug Fails Late-Stage Study $HRMY $IWMW $AOR https://stocktwits.com/news/equity/markets/harmony-biosciences-stock-slumps-after-rare-genetic-disorder-drug-fails-late-stage-study/chD1BhBR3Ed
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 24 at 11:58 AM
Acadia Healthcare Stock Surges Pre-Market After Activist Hedge Fund Reportedly Seeks Board Revamp $ACHC $EAOR $AOR https://stocktwits.com/news/equity/markets/acadia-health-care-stock-surges-pre-market-after-activist-hedge-fund-reportedly-seeks-board-revamp/chD1bdjR33W
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 24 at 11:27 AM
Acadia Pharmaceuticals’ Investigational Drug For Rare Genetic Disorder Fails In Late-Stage Study $ACAD $AOR $AVSU https://stocktwits.com/news/equity/markets/acadia-pharmaceuticals-investigational-drug-for-rare-genetic-disorder-fails-in-late-stage-study/chD1Gf0R33B
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 23 at 11:41 AM
Moderna Says Updated mNEXSPIKE Covid Shot Demonstrated Robust Immune Response In Study $MRNA $EAOR $AOR https://stocktwits.com/news/equity/markets/moderna-says-updated-mnexspike-covid-shot-demonstrated-rbust-immune-response-in-study/chDhMlcR35J
1 · Reply
StocktwitsNews
StocktwitsNews Sep. 16 at 6:19 PM
BWXT Shares Climb On Department of Energy’s $1.5B Contract $BWXT $AVUS $SMCO $AOR https://stocktwits.com/news/equity/markets/bwxt-shares-climb-on-department-of-energy-s-1-5-b-contract/chwyqEARdzw
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 12 at 3:18 PM
RH Stock Sees Slew Of Downgrades, Price Target Cuts From Wall Street As Trump Tariffs Bite $RH $EAOR $AOR $AVSU https://stocktwits.com/news/equity/markets/rh-stock-sees-slew-price-target-cuts-from-wall-street-as-trump-tariffs-bite/chw8MrGRdDN
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 5 at 3:02 PM
Legend Biotech Considering Second Listing Outside US: Report $LEGN $AOR $AAXJ https://stocktwits.com/news/equity/markets/legend-biotech-considering-second-listing-outside-us-report/chwIifbRdqJ
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 14 at 1:49 PM
Hertz Expands Program Allowing Prolonged 3-Day Test Drives Before Vehicle Purchase To Over 100 Cities $HTZ $IWMW $AOR https://stocktwits.com/news/equity/markets/hertz-expands-program-allowing-prolonged-3-day-test-drives-before-vehicle-purchase-to-over-100-cities/chsRlcNRdOh
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 14 at 11:17 AM
Schrödinger Discontinues Clinical Program After Two Patient Deaths $SDGR $IWMW $AOR https://stocktwits.com/news/equity/markets/schrodinger-discontinues-clinical-program-after-two-patient-deaths/chsR0RyRdOb
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 28 at 6:07 PM
Revvity CEO Acknowledges Challenges In Immunodiagnostics Business In China: Retail Terms Stock Drop An ‘Overreaction’ $RVTY $AVUS $AOR https://stocktwits.com/news/equity/markets/revvity-ceo-acknowledges-challenges-in-immunodiagnostics-business-in-china/choeD0pR5xh
0 · Reply